Sept 4 (Reuters) - Photocure ASA PHO.OL :
* Announces submission of application for Hexvix marketing authorization in Australia by its partner and exclusive distributor, Juno Pharmaceuticals
* Says will receive a milestone payment of 250,000 euros ($278,350) upon approval of Hexvix in Australia, estimated to occur in H2 2016 Source text for Eikon: ID:nHUG4YTnlx
Further company coverage: PHO.OL ($1 = 0.8981 euros) (Gdynia Newsroom)